These picks are supported by government

Article Excerpt

Both Calian and Extendicare have a major plus on their side during this time of COVID-19 uncertainty. Specifically, the two get most of their revenue from governments. For Calian, revenue generated from various departments and agencies of the Canadian federal government currently represents about 69% of the total. And with more than 90% of its business now government funded, Extendicare and its investors are also well positioned to weather the pandemic. CALIAN GROUP $53.00 is a buy. The Ottawa-based company (Toronto symbol CGY; TSINetwork Rating: Extra Risk) (; Shares outstanding: 9.6 million; Market cap: $506.1 million; Dividend yield: 2.1%) has now soared to new all-time highs. We think it will provide you with further gains. Investors benefit from the company’s two main operations: Business and Technology Services (70% of revenue) provides clients with engineers, health-care workers and other skilled professionals on a contract basis; and Systems Engineering (30%) sells hardware and software for testing and operating satellite and other communication systems. In its fiscal 2020 second quarter,…

You are trying to access subscriber-only content.

To read this article, you may subscribe or sign in.
If you are already a subscriber, log in here.

If you wish to become a subscriber, click here. Or you may enjoy access to all our publications when you become a Member of Pat McKeough's Inner Circle Pro.